Pharmacology of agents used in bone marrow transplant conditioning regimens
- 1 November 1992
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 13 (3), 241-270
- https://doi.org/10.1016/1040-8428(92)90092-5
Abstract
No abstract availableKeywords
This publication has 148 references indexed in Scilit:
- Central Nervous System Toxicity after Liver TransplantationNew England Journal of Medicine, 1987
- Marrow Transplantation for Acute Nonlymphocytic Leukemia after Treatment with Busulfan and CyclophosphamideNew England Journal of Medicine, 1983
- Nephrotoxicity of Cyclosporin a after Allogeneic Marrow TransplantationNew England Journal of Medicine, 1981
- Clinical and Immunologic Effects of Fractionated Total Lymphoid Irradiation in Refractory Rheumatoid ArthritisNew England Journal of Medicine, 1981
- EFFECT OF IMMUNOSUPPRESSIVE THERAPY FOR RENAL ALLOGRAFTS ON THE NUMBER OF CIRCULATING SHEEP RED BLOOD CELL ROSETTING CELLSTransplantation, 1975
- RADIATION-RELATED PERICARDIAL EFFUSIONS IN PATIENTS WITH HODGKINʼS DISEASEMedicine, 1975
- 4′-Demethyl-epipodophyllotoxin-β-D-thenylidene-glucoside (PTG) in the treatment of malignant intracranial neoplasmsCancer, 1974
- Induction of tolerance to skin homografts with a methylhydrazine derivative. Synergism with antilymphocytic serum and morphologic responses of the lymphoid systemInflammation Research, 1970
- Effect of cytosine arabinoside 5′-triphosphate on mammalian DNA polymeraseBiochemical and Biophysical Research Communications, 1969
- Symptomatic constrictive pericarditis developing 45 years after radiation therapy to the mediastinum: A review of radiation pericarditisAmerican Heart Journal, 1969